Total Payments
$6,827
2024 Payments
$1,867
Companies
42
Transactions
392
Medicare Patients
94
Medicare Billing
$5,497
Payment Breakdown by Category
Food & Beverage$6,795 (99.5%)
Education$32.27 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,795 | 391 | 99.5% |
| Education | $32.27 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,393 | 97 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $725.02 | 38 | $0 (2024) |
| Lilly USA, LLC | $448.91 | 28 | $0 (2024) |
| Novo Nordisk Inc | $433.88 | 22 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $377.11 | 19 | $0 (2024) |
| Nestle HealthCare Nutrition Inc. | $362.52 | 18 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $306.83 | 15 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $241.03 | 26 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $202.86 | 10 | $0 (2021) |
| Amgen Inc. | $192.88 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,867 | 95 | ABBVIE INC. ($480.27) |
| 2023 | $1,660 | 91 | ABBVIE INC. ($380.44) |
| 2022 | $1,766 | 112 | ABBVIE INC. ($295.11) |
| 2021 | $1,535 | 94 | AbbVie Inc. ($237.13) |
All Payment Transactions
392 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Obesity | ||||||
| 10/31/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: Oncology | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.35 | General |
| Category: Cardiovascular | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 77 | $9,532 | $3,433 |
| 2022 | 3 | 43 | 47 | $5,132 | $2,064 |
Total Patients
94
Total Services
124
Medicare Billing
$5,497
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 37 | $7,400 | $2,651 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $1,820 | $563.22 | 30.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 26 | $312.00 | $218.40 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $2,600 | $1,053 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $2,340 | $964.58 | 41.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 16 | $192.00 | $47.04 | 24.5% |
About Julie Leffler, ARNP
Julie Leffler, ARNP is a Nurse Practitioner healthcare provider based in Milwaukie, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2019. The National Provider Identifier (NPI) number assigned to this provider is 1750855425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julie Leffler, ARNP has received a total of $6,827 in payments from pharmaceutical and medical device companies, with $1,867 received in 2024. These payments were reported across 392 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,795).
As a Medicare-enrolled provider, Leffler has provided services to 94 Medicare beneficiaries, totaling 124 services with total Medicare billing of $5,497. Data is available for 2 years (2022–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Milwaukie, OR
- Active Since 01/16/2019
- Last Updated 11/07/2022
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1750855425
Products in Payments
- ZENPEP (Drug) $545.86
- UBRELVY (Drug) $471.41
- QULIPTA (Drug) $422.63
- NURTEC ODT (Drug) $418.06
- VRAYLAR (Drug) $378.74
- REXULTI (Drug) $373.48
- BREZTRI (Drug) $323.37
- Kerendia (Drug) $306.83
- FARXIGA (Drug) $244.84
- JARDIANCE (Drug) $238.29
- Ozempic (Drug) $225.09
- Otezla (Drug) $180.97
- MOUNJARO (Drug) $161.09
- LYBALVI (Drug) $132.95
- AIRSUPRA (Drug) $128.44
- Wegovy (Drug) $119.04
- BELSOMRA (Drug) $109.07
- TRULICITY (Drug) $105.22
- Cologuard Collection Kit (Device) $94.92
- ELIQUIS (Drug) $92.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.